These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27931556)

  • 1. Non-physician health workers for improving adherence to medications and healthy lifestyle following acute coronary syndrome: 24-month follow-up study.
    Sharma KK; Gupta R; Mathur M; Natani V; Lodha S; Roy S; Xavier D
    Indian Heart J; 2016; 68(6):832-840. PubMed ID: 27931556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial.
    Xavier D; Gupta R; Kamath D; Sigamani A; Devereaux PJ; George N; Joshi R; Pogue J; Pais P; Yusuf S
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):244-253. PubMed ID: 26857999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial.
    Ho PM; Lambert-Kerzner A; Carey EP; Fahdi IE; Bryson CL; Melnyk SD; Bosworth HB; Radcliff T; Davis R; Mun H; Weaver J; Barnett C; Barón A; Del Giacco EJ
    JAMA Intern Med; 2014 Feb; 174(2):186-93. PubMed ID: 24247275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction.
    Faridi KF; Peterson ED; McCoy LA; Thomas L; Enriquez J; Wang TY
    JAMA Cardiol; 2016 May; 1(2):147-55. PubMed ID: 27437885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving patient adherence to secondary prevention medications 6 months after an acute coronary syndrome: observational cohort study.
    Brieger D; Chow C; Gullick J; Hyun K; D'Souza M; Briffa T;
    Intern Med J; 2018 May; 48(5):541-549. PubMed ID: 29345403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing prevention and guideline-concordant care in Montenegro.
    Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
    Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design.
    Boulmpou A; Kartas A; Farmakis I; Zafeiropoulos S; Nevras V; Papadimitriou I; Tampaki A; Vlachou A; Lillis L; Koutsakis A; Karvounis H; Giannakoulas G
    Hellenic J Cardiol; 2019; 60(4):249-253. PubMed ID: 30352291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of a randomized controlled trial evaluating community health worker-based interventions for the secondary prevention of acute coronary syndromes in India (SPREAD).
    Kamath DY; Xavier D; Gupta R; Devereaux PJ; Sigamani A; Hussain T; Umesh S; Xavier F; Girish P; George N; Thomas T; Chidambaram N; Joshi R; Pais P; Yusuf S
    Am Heart J; 2014 Nov; 168(5):690-7. PubMed ID: 25440797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of different intervention models on adherence to secondary prevention therapies in patients with acute coronary syndrome].
    Liu J; Wang W; Liu J; Wang Y; Qi Y; Sun JY; Zhao D
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):124-130. PubMed ID: 29495236
    [No Abstract]   [Full Text] [Related]  

  • 10. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
    Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A
    Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medications adherence post-primary percutaneous coronary intervention in acute myocardial infarction: A population-based cohort study.
    Rahhal A; Mahfouz A; Khir F; Okleh N; Aljundi AH; AlKhalaila O; Hamid Y; Al-Amri M; Al-Yafei SA; Al Suwaidi J; Al-Qahtani A; Arafa S; Arabi AR
    J Clin Pharm Ther; 2021 Jun; 46(3):772-779. PubMed ID: 33382471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge.
    Hassan Y; Kassab Y; Abd Aziz N; Akram H; Ismail O
    J Clin Pharm Ther; 2013 Apr; 38(2):97-100. PubMed ID: 23441979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol.
    Chow CK; Thiagalingam A; Santo K; Kok C; Thakkar J; Stepien S; Billot L; Jan S; Joshi R; Hillis GS; Brieger D; Chew DP; Rådholm K; Atherton JJ; Bhindi R; Collins N; Coverdale S; Hamilton-Craig C; Kangaharan N; Maiorana A; McGrady M; Shetty P; Thompson P; Rogers A; Redfern J
    BMJ Open; 2018 Jan; 8(1):e019463. PubMed ID: 29374674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related differences in factors associated with the underuse of recommended medications in acute coronary syndrome patients at least one year after hospital discharge.
    Jin H; Tang C; Wei Q; Chen L; Sun Q; Ma G; Liu N
    BMC Cardiovasc Disord; 2014 Sep; 14():127. PubMed ID: 25252927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported use of evidence-based medicine and smoking cessation 6 - 9 months after acute coronary syndrome: a single-centre perspective.
    Griffiths B; Lesosky M; Ntsekhe M
    S Afr Med J; 2014 Jun; 104(7):483-7. PubMed ID: 25214049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective secondary prevention through cardiac rehabilitation after coronary revascularization and predictors of poor adherence to lifestyle modification and medication. Results of the ICAROS Survey.
    Griffo R; Ambrosetti M; Tramarin R; Fattirolli F; Temporelli PL; Vestri AR; De Feo S; Tavazzi L;
    Int J Cardiol; 2013 Aug; 167(4):1390-5. PubMed ID: 22575623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary prevention after acute myocardial infarction: drug adherence, treatment goals, and predictors of health lifestyle habits. The BLITZ-4 Registry.
    Urbinati S; Olivari Z; Gonzini L; Savonitto S; Farina R; Del Pinto M; Valbusa A; Fantini G; Mazzoni A; Maggioni AP;
    Eur J Prev Cardiol; 2015 Dec; 22(12):1548-56. PubMed ID: 25452625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cluster randomized controlled trial of Delayed Educational Reminders for Long-term Medication Adherence in ST-Elevation Myocardial Infarction (DERLA-STEMI).
    Schwalm JD; Ivers NM; Natarajan MK; Taljaard M; Rao-Melacini P; Witteman HO; Zwarenstein M; Grimshaw JM
    Am Heart J; 2015 Nov; 170(5):903-13. PubMed ID: 26542498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nurse-led telephone-based follow-up of secondary prevention after acute coronary syndrome: One-year results from the randomized controlled NAILED-ACS trial.
    Huber D; Henriksson R; Jakobsson S; Mooe T
    PLoS One; 2017; 12(9):e0183963. PubMed ID: 28886083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.